Search results (9)
« Back to NewsThe latest news, stories and exciting findings from across the Oxford cancer research community
World Chronic Lymphoid Leukaemia Day 2021
1 September 2021
Researchers from Oxford University and OUH are joining celebrations for the first world CLL day on 1 September 2021.
Understanding the developmental origins of resistant infant leukaemia
28 September 2020
The Roy and Milne labs are investigating the developmental origins of infant leukaemia and its influence on the biology of the disease
Understanding clonal haematopoiesis for COVID and cancer
24 September 2020
Prof Paresh Vyas and team have been investigating how a better understanding of clonal haematopoiesis can be applied to both cancer and to care of COVID patients
Helping blood cancer patients in the COVID era
22 September 2020
The Oxford-led UK Coronavirus Cancer Monitoring Project was launched earlier this year to help clinicians better treat blood cancer patients in a safe way during the COVID-pandemic
Tackling blood cancers in Tanzania and Uganda
15 September 2020
Scientists from Tanzania, Uganda and Oxford University have teamed up in a new child blood cancer program
Balancing the benefits and risks of radiotherapy for Hodgkin lymphoma
8 September 2020
Dr Rebecca Shakir is devising a tool to allow some blood cancer patients to make more informed decisions about the risks and benefits of their radiotherapy treatment
Harnessing immune cell therapy in cancer
1 September 2020
Prof Paresh Vyas and his team are investigating how to harness the power of T cells as therapies for patients with a range of blood cancers
The impact of COVID-19 on cancer patients
24 August 2020
A new study from the UK Coronavirus Cancer Monitoring Project (UKCCMP) has investigated which cancer patients may be more susceptible to the impacts of coronavirus
TP53 gene determines severe blood cancer development
12 August 2020
A new study has found that the allelic appearance of the TP53 gene has great impact on development of severe types of blood cancer